16 December 2021

IMABGEN Project, an innovative platform in immunotherapies

Lyon, December 16, 2021 – The IMABGEN Platform project, an innovative service for the generation of therapeutic antibodies carried by BIOTEM, CALIXAR and the CNRS / Université Claude Bernard Lyon 1, is one of the laureates of the ‘‘R&D Booster’’ 2021 program driven by the Region Auvergne-Rhône-Alpes. Read more